SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016125
Filing Date
2022-04-27
Accepted
2022-04-27 16:53:59
Documents
6
Period of Report
2022-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A avro-def14a_20220608.htm DEF 14A 1358000
2 GRAPHIC goqvqvb5v2t3000005.jpg GRAPHIC 423637
3 GRAPHIC goqvqvb5v2t3000004.jpg GRAPHIC 576994
4 GRAPHIC goqvqvb5v2t3000003.jpg GRAPHIC 22640
5 GRAPHIC goqvqvb5v2t3000002.jpg GRAPHIC 6591
6 GRAPHIC goqvqvb5v2t3000001.jpg GRAPHIC 22640
  Complete submission text file 0001564590-22-016125.txt   2809069
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38537 | Film No.: 22860612
SIC: 2836 Biological Products, (No Diagnostic Substances)